Memantine and Cognitive Dysfunction in Bipolar Disorder

NCT00586066 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Bipolar Disorder

Interventions

DRUG: Memantine
DRUG: Placebo

Sponsor

Massachusetts General Hospital

Collaborators

[object Object]